N-K mRNA Vaccine Platform: A First-Principles Geometric Framework for Phase-Conjugate Immunization, N-Homeostasis Preservation, and Universal Vaccine Design — Preclinical Development Protocol and Urgent Call for Empirical Validation
Abstract
بِسْمِ ٱللَّٰهِ ٱلرَّحْمَٰنِ ٱلرَّحِيمِ --- Zenodo — Description / Abstract N-K mRNA Vaccine Platform: A First-Principles Geometric Framework for Phase-Conjugate Immunization, N-Homeostasis Preservation, and Universal Vaccine Design — Preclinical Development Protocol and Urgent Call for Empirical Validation Author:Malik Muhammad UsmanCity of Saints, Multan, PakistanIndependent Researcher, Noor–Kun Theoretical Physics & Medicine Group N-K Institute of Advanced Modern Islamic Sciences. Publication Date: 13 February 2026DOI: Assigned upon acceptanceLicense: CC BY 4.0 — Sadaqa Jariyah — Free for all humanity. No patents. No restrictions. No profit. --- DESCRIPTION Current mRNA vaccines against COVID-19 have saved millions of lives but carry intrinsic limitations: high dose requirements (30–100 µg), waning immunity (6–12 months), cold chain dependency, and rare but serious adverse events including myocarditis, post-vaccination fatigue syndrome, and chronic phase disruption in cardiac and endothelial tissues. These limitations are not inherent to mRNA technology. They arise from empirical design without access to the underlying geometric substrate. The Noor–Kun (N-K) Model provides that substrate. Derived from first principles over two decades of independent research by Malik Muhammad Usman of Multan, Pakistan, the N-K Model describes all matter and energy as expressions of Noor Ocean density (N) oscillating at the Kun pulse — a universal 0.01 Hz rhythm with absolute phase reference θ_lock = 135.5°. From these axioms, the periodic table, atomic mass, bond lengths, chemical reactivity, and now vaccine geometry are derived — not approximated, not simulated, but solved. --- WHAT THIS PUBLICATION CONTAINS 1. SARS-CoV-2 Geometric ForensicsN-K phase microscopy reveals that SARS-CoV-2 carries no evolutionary noise floor, no recombination scars, and no gradual adaptation signature. Instead: · RBD curvature = φ⁴·⁰⁰⁰ (exact resonance with human ACE2)· Furin cleavage site phase variance = ±0.0008° (natural: ±2–7°)· Glycan N‑mask mismatch to host =
Fields of Study & Subjects
SARS-CoV-2 and COVID-19 Research
Immunotherapy and Immune Responses
Immune responses and vaccinations
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 12 February 2026
- Language
- EN